fluorodeoxyglucose f18 has been researched along with 1-(3-chlorophenyl)piperazine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreasen, P; Hommer, D; Linnoila, M; Momenan, R; Rawlings, R; Rio, D; Ruttimann, U; Williams, W; Zametkin, A | 1 |
Buchsbaum, MS; Goodman, M; Hazlett, EA; Koenigsberg, H; Mitropoulou, V; New, AS; Platholi, J; Reynolds, D; Shaw, RB; Siever, LJ; Silverman, J; Sprung, L | 1 |
Buchsbaum, MS; Flory, J; Goodman, M; Hazlett, EA; Haznedar, MM; Koenigsberg, HW; Mitelman, SA; New, AS; Newmark, R; Siever, LJ; Trisdorfer, R | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.
Topics: Adult; Alcoholism; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Piperazines; Reference Values; Regression Analysis; Serotonin Receptor Agonists; Tomography, Emission-Computed | 1997 |
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression.
Topics: Aggression; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Impulsive Behavior; Piperazines; Prefrontal Cortex; Serotonin Receptor Agonists; Tomography, Emission-Computed | 2002 |
Amygdala-prefrontal disconnection in borderline personality disorder.
Topics: Adult; Aggression; Amygdala; Atrophy; Borderline Personality Disorder; Emotions; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Impulsive Behavior; Male; Middle Aged; Neural Pathways; Piperazines; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Serotonin Receptor Agonists | 2007 |